Schroder Investment Management Group cut its stake in Valmont Industries (NYSE:VMI) by 1.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 689,795 shares of the industrial products company’s stock a
It hardly seems possible, but life just got a lot more complicated in Washington, D.C. The U.S. Department of Justice still insists marijuana has zero medical benefits, yet the Food and Drug Administration just approved the first drug derived from a marijuana plant.
One of the problems with investing in companies, says Nassim Taleb in his book Antifragile, is that the interests of investors and company executives aren’t always aligned.
Because executives earn a salary and bonuses that often dwarf the value of stock that they own in the company, they generally benefit more from the upside of taking risk without suffering as much downside. The harm....More>>>
There were six initial public offerings (IPOs) last week, including the largest biotech IPO of the year to date. The total amount raised reached a combined $827 million, well above the anticipated level of $731 million, and the average first-day pop was around 6.7%. A total of six IPOs seeking $763 million in financing are on the calendar for the coming week.
Recent economic data for the US suggests that the stock market’s hissy fit this year has been a false signal for anticipating a new recession. That’s not surprisingthe short-term noise in equity prices is a constant challenge for business-cycle analysis and so it’s not uncommon that market volatility will lead us astray at times. That’s always been the case and nothing’s....More>>>
SAN FRANCISCO The Amazon Go grocery store, now in the testing stage in Seattle, sounds like a dream come true for holiday shoppers waiting in long lines.
The underlying technology seems to be routed interra firma, however, a mix of cameras, microphones and the massive servers that Amazon uses to run its cloud computing service and power digital assistant Alexa.
Hearsay data has found that 10% of compliance risks identified by monitoring language on social and digital platforms are actually risky. The firm’s Risk Meter uses machine learning to prioritize risks it identifies based on almost 100 million annual interactions processed on the Hearsay platform, according to a statement.
“Today, supervision teams are tasked to do more than ever....More>>>
Walt Disney Will Survive, The ESPN Problem is Overblown
Walt Disney (NYSE:DIS) stock has been one of the more notable laggards this year, trailing the Consumer Discret Sel Sect SPDR ETF (NYSEMKT:XLY) and the broader market by a wide margin of more than 10-percentage points. DIS stock has a YTD return of -4.87% compared to a gain of 5.33% by XLY and 7.87% by the S&P 500, respectively.....More>>>
Athenex Inc (NASDAQ:ATNX) shares saw an uptick in trading volume on Friday . 4,670,100 shares traded hands during trading, an increase of 1,213% from the previous session’s volume of 355,816 shares.The stock last traded at $19.05 and had previously closed at $18.62.
Media coverage about Kopin (NASDAQ:KOPN) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of ne
Wall Street brokerages predict that Neurocrine Biosciences, Inc. (NASDAQ:NBIX) will report ($0.15) earnings per share for the current quarter, Zacks Investment Research reports. Six analysts have provided estimates for Neurocrine Biosciences’ earnings, with the highest EPS estimate coming
Oppenheimer set a $120.00 target price on Neurocrine Biosciences (NASDAQ:NBIX) in a report published on Monday morning. The brokerage currently has a buy rating on the stock. Oppenheimer also issued estimates for Neurocrine Biosciences’ FY2021 earnings at $7.03 EPS and FY2022 earnings at